UG Healthcare (Catalist:8K7) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

8K7 Overzicht aandelen

UG Healthcare Corporation Limited, een investeringsholding, produceert en verkoopt wegwerphandschoenen.

8K7 fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	4/6
Dividenden	0/6

Beloningen

Risicoanalyse

De winst is de afgelopen 5 jaar met 23.8% per jaar gedaald

Heeft geen betekenisvolle marktkapitalisatie ( SGD82M )

UG Healthcare Corporation Limited Concurrenten

Medtecs International

Catalist:546

S$80.1m

Riverstone Holdings

SGX:AP4

S$1.3b

Vicplas International

SGX:569

S$51.6m

Singapore Institute of Advanced Medicine Holdings

Catalist:9G2

S$89.1m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor UG Healthcare
Historische aandelenkoersen
Huidige aandelenkoers	S$0.13
52 Week Hoogtepunt	S$0.23
52 Week Laag	S$0.086
Bèta	0.85
11 maand verandering	5.69%
3 maanden verandering	4.84%
1 Jaar Verandering	36.84%
33 jaar verandering	-62.32%
5 jaar verandering	132.15%
Verandering sinds IPO	56.00%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	8K7	SG Medical Equipment	SG Markt
7D	2.4%	0.3%	0.5%
1Y	36.8%	40.0%	10.9%

Rendement versus industrie: 8K7 presteerde slechter dan de SG Medical Equipment -sector, die het afgelopen jaar een rendement van 38.7 % opleverde.

Rendement versus markt: 8K7 overtrof de SG markt, die het afgelopen jaar een rendement opleverde van 9.4 %.

Prijsvolatiliteit

Is 8K7's price volatile compared to industry and market?
8K7 volatility
8K7 Average Weekly Movement	6.5%
Medical Equipment Industry Average Movement	6.5%
Market Average Movement	4.7%
10% most volatile stocks in SG Market	15.3%
10% least volatile stocks in SG Market	2.5%

Stabiele aandelenkoers: 8K7 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit van 8K7 is het afgelopen jaar gedaald van 12% naar 7%.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1989	1,054	Keck Keong Lee	www.ughealthcarecorporation.com

UG Healthcare Corporation Limited, een investeringsholding, produceert en verkoopt wegwerphandschoenen. Het bedrijf is actief via de segmenten Latex Onderzoekshandschoenen, Nitril Onderzoekshandschoenen en Andere Aanvullende Producten. Het distribueert aanvullende producten, waaronder chirurgische handschoenen, vinyl en cleanroom wegwerphandschoenen, gezichtsmaskers en andere medische wegwerpartikelen.

UG Healthcare Corporation Limited Samenvatting

Hoe verhouden de winst en inkomsten van UG Healthcare zich tot de beurswaarde?
8K7 fundamentele statistieken
Marktkapitalisatie	S$81.10m
Inkomsten(TTM)	-S$6.06m
Inkomsten(TTM)	S$115.21m

0.7x

P/S-verhouding

-13.4x

Koers/Winstverhouding

Is 8K7 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
8K7 resultatenrekening (TTM)
Inkomsten	S$115.21m
Kosten van inkomsten	S$89.34m
Brutowinst	S$25.87m
Overige uitgaven	S$31.92m
Inkomsten	-S$6.06m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.0097
Brutomarge	22.45%
Nettowinstmarge	-5.26%
Schuld/Eigen Vermogen Verhouding	26.6%

Hoe presteerde 8K7 op de lange termijn?

Bekijk historische prestaties en vergelijking

8K7 Overzicht aandelen

Beloningen

Risicoanalyse

UG Healthcare Corporation Limited Concurrenten

Catalist:546

S$80.1m

SGX:AP4

S$1.3b

SGX:569

S$51.6m

Catalist:9G2

S$89.1m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

UG Healthcare Corporation Limited (Catalist:8K7) completed the acquisition of 50% stake in UG NITREX, S. L. from Afaprot, S. L. and Martínez for €0.5 million.

First half 2024 earnings released: S$0.008 loss per share (vs S$0.008 loss in 1H 2023)

New major risk - Revenue and earnings growth

UG Healthcare Corporation Limited to Report First Half, 2024 Results on Feb 13, 2024

Recent updates

Full year 2024 earnings released: S$0.01 loss per share (vs S$0.033 loss in FY 2023)

UG Healthcare Corporation Limited to Report Fiscal Year 2024 Results on Aug 29, 2024

UG Healthcare Corporation Limited (Catalist:8K7) completed the acquisition of 50% stake in UG NITREX, S. L. from Afaprot, S. L. and Martínez for €0.5 million.

First half 2024 earnings released: S$0.008 loss per share (vs S$0.008 loss in 1H 2023)

New major risk - Revenue and earnings growth

UG Healthcare Corporation Limited to Report First Half, 2024 Results on Feb 13, 2024

UG Healthcare Corporation Limited Announces Appointment of Ng Lee Eng as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

New minor risk - Share price stability

UG Healthcare Corporation Limited Announces Cessation Vincent Leow as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

Full year 2023 earnings released: S$0.033 loss per share (vs S$0.059 profit in FY 2022)

UG Healthcare Corporation Limited, Annual General Meeting, Oct 30, 2023

Full year 2023 earnings released: S$0.033 loss per share (vs S$0.059 profit in FY 2022)

New minor risk - Financial data availability

First half 2023 earnings released: S$0.008 loss per share (vs S$0.034 profit in 1H 2022)

UG Healthcare Corporation Limited to Report First Half, 2023 Results on Feb 14, 2023

Less than half of directors are independent

UG Healthcare Corporation Limited Approves Special Cash Dividend for the Financial Year Ended 30 June 2022, Payable on 16 December 2022

UG Healthcare Corporation Limited (Catalist:8K7) entered into a share sale agreement to acquire Indigo Teguh Sdn Bhd from Lee Keck Keong for MYR 100.

Full year 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited, Annual General Meeting, Oct 28, 2022

Consensus revenue estimates fall by 12%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited Recommends Tax Exempt Special Dividend for Fiscal Year 2022

Less than half of directors are independent

Now 20% undervalued after recent price drop

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited to Report First Half, 2022 Results on Feb 11, 2022

UG Healthcare Corporation Limited to Report First Half, 2022 Results on Feb 11, 2022

Price target decreased to S$0.44

Full year 2021 earnings released: EPS S$0.19 (vs S$0.023 in FY 2020)

Price target decreased to S$0.55

Less than half of directors are independent

UG Healthcare Corporation Limited Provides Update on Covid-19 Situation in the Group's Manufacturing Division in Malaysia

Company Secretary Kar Yeoh has left the company

Third quarter 2021 earnings released: EPS S$0.056 (vs S$0.011 in 3Q 2020)

Price target decreased to S$0.99

Second quarter 2021 earnings released

UG Healthcare Corporation Limited to Report First Half, 2021 Results on Feb 04, 2021

New 90-day low: S$0.36

New 90-day low: S$0.23

New 90-day low: S$0.60

New 90-day low: S$0.64

First quarter 2021 earnings released: EPS S$0.039

Analysts update estimates

Annual earnings released: Revenue and earnings beat expectations

Full year earnings released - EPS S$0.023

Analysts increase revenue estimates to S$240.3m

UG Healthcare Corporation Limited has completed a Follow-on Equity Offering in the amount of SGD 19.0875 million.

Analysts increase revenue estimates to S$180.9m

Full year earnings released - EPS S$0.068

New 90-day high - S$2.91

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

UG Healthcare Corporation Limited Samenvatting

0.7x

-13.4x

Inkomsten en omzet